loader2
Partner With Us NRI

Lincoln Pharmaceuticals Ltd share Price Today

Company details

606.00
615.35
391.95
755.15
6M Return -1.49%
1Y Return 50.41%
Mkt Cap.(Cr) 1,216.52
Volume 17,399
Div Yield 0.30%
OI
-
OI Chg %
-
Volume 17,399

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Lincoln Pharmaceuticals Ltd shares SWOT Analysis

Strengths (10)

  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth
  • Good quarterly growth in the recent results

Weakness (1)

  • Declining Revenue every quarter for the past 2 quarters

Opportunity (0)

Data not found

Threats (1)

  • Promoter decreasing their shareholding

Resistance and support

R1 613.1
R2 622.6
R3 631.8
Pivot

603.90

S1 594.4
S2 585.2
S3 575.7
EMA SMA
595.0
593.9
598.0
574.0
587.2
587.0
614.1
596.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-11-21 669.47 193913 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2023-11-21 668.94 193913 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2023-11-02 539.99 317188 NSE
Name Category Shares
Munjal Mahendrabhai Patel PROMOTER 13.13%
Aashish Rajanibhai Patel PROMOTER 10.6%
Rajanikant Gulabdas Patel PROMOTER 3.78%
Mahendrabhai Gulabdas Patel PROMOTER 3.37%
Kailashben Mahendrabhai Patel PROMOTER 2.4%
Hashmukhbhai Ishwarlal Patel PROMOTER 1.87%
Anand Arvinbhai Patel PROMOTER 1.66%
Shivani B. Shah PROMOTER 1.03%
Mansi Munjal Patel PROMOTER 1%
Hansaben Arvindbhai Patel PROMOTER 0.88%
Patel Nishitkumar Maheshbhai PROMOTER 0.77%
Dharmisthaben Bhagirath Patel PROMOTER 0.62%
Arvindbhai Gulabdas Patel PROMOTER 0.55%
Sunmed Corporation Llp PROMOTER 2.5%
Downtown Travels Llp PROMOTER 2.37%
Downtown Finance Pvt. Ltd. PROMOTER 0.53%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Lincoln Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Lincoln Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 607.35 1,473.50 1,547.85 4,539.10 1,083.95
% Change 0.64 0.17 0.19 0.78 -0.43
Mcap Cr 1,216.52 353,542.01 124,968.30 120,499.03 109,070.73
Revenue TTM Cr 510.31 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 72.90 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 12.96 35.25 29.28 74.76 28.43
1 Year Return 50.41 48.55 53.08 27.28 94.94
ROCE 21.61 16.79 14.76 19.30 16.25
ROE 15.59 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 502.47 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,174.76 13,274.51
LAST 3M 100,774.38 -18,853.99
LAST 6M 177,467.27 -3,043.74
LAST 12M 289,801.20 99,689.80

Lincoln Pharmaceuticals Ltd Information

Stock PE (TTM)
12.96
Promoter Holding
49.53%
Book Value
295.9799
ROCE
21.61%
ROE
15.59%
Description
  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. `95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.`96 to part-finance its project. The Company launched Next Generation Progesterone Therapy "ProlinSpray" during the year 2018. During the year 2021-22, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.

Registered Address

Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060

Tel : 91-079-67778000
Email : cs:lincolnpharma.com; investor:lincolnpharma.com
Website : http://www.lincolnpharma.com
Registrar

Sharepro Services India Pvt Lt

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531633
NSE Code : LINCOLN
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE405C01035

FAQ’s on Lincoln Pharmaceuticals Ltd Shares

You can buy Lincoln Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lincoln Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 21, 2024 12:49 PM the closing price of Lincoln Pharmaceuticals Ltd was Rs.607.35.

The latest PE ratio of Lincoln Pharmaceuticals Ltd as of Jun 21, 2024 12:49 PM is 12.96

The latest PB ratio of Lincoln Pharmaceuticals Ltd as of Jun 21, 2024 12:49 PM is 0.49

The 52-week high of Lincoln Pharmaceuticals Ltd share price is Rs. 755.15 while the 52-week low is Rs. 391.95

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 21, 2024 12:49 PM, the market cap of Lincoln Pharmaceuticals Ltd stood at Rs. 1,216.52.

Download App

Download Our App

Play Store App Store
market app